Insider Sell: Sukumar Nagendran Sells 200,000 Shares of Taysha Gene Therapies Inc (TSHA)
Related Stocks: TSHA
Read the full articleYou might also wanna read
Taysha's R&D Chief Sold $1.2 Million in Stock After a 149% Run
Nagendran Sukumar executed the sale under a pre-established Rule 10b5-1 trading plan, retaining 936,410 shares worth $5.94 million.
Shuttle Pharma stock jumps 41% as turnover hits 82 times its share base
NEW YORK, July 14, 2026, 16:13 EDT Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) shares closed 40.5% higher at $4.16 on Tuesday after
Attovia Therapeutics files for Nasdaq IPO to fund immune-disease biologics
Tao Fu's San Carlos biotech is seeking an ATTO listing before disclosing price range, share count or valuation.
GEM and Senhwa Biosciences have formally executed a Share Purchase Agreement for up to NT$500 million
TAIPEI and SAN DIEGO, July 15, 2026 /PRNewswire/ -- GEM Global Yield LLC SCS ("GEM") has executed a Share Purchase Agreement (the "SPA") wit
A Veracyte Insider Sold 24,000 Company Shares for $1.1 Million. Here's a Deeper Look at the Transaction.
This genomic diagnostics company saw a notable insider sale, as shares have surged over 70% in the past year.
GlaxoSmithKline announces sale of shares in Quest Diagnostics Inc.
GSK announces it's sold 5,749,157 shares of common stock, par value of $0.01 per share of Quest Diagnostics Inc.
Comments
Sign in to join the conversation.
No comments yet. Be the first.